Kiewe P - Search Results

1

Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.

Roth P, Martus P, Kiewe P, Möhle R, Klasen H, Rauch M, Röth A, Kaun S, Thiel E, Korfel A, Weller M. Roth P, et al. Among authors: kiewe p. Neurology. 2012 Aug 28;79(9):890-6. doi: 10.1212/WNL.0b013e318266fcb2. Epub 2012 Aug 15. Neurology. 2012. PMID: 22895585 Clinical Trial.

2

High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma.

Kiewe P, Loddenkemper C, Anagnostopoulos I, Reinwald M, Thiel E, Korfel A. Kiewe P, et al. Neuro Oncol. 2007 Apr;9(2):96-102. doi: 10.1215/15228517-2006-037. Epub 2007 Feb 14. Neuro Oncol. 2007. PMID: 17301290 Free PMC article.

3

Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.

Kiewe P, Fischer L, Martus P, Thiel E, Korfel A. Kiewe P, et al. Cancer. 2008 Apr 15;112(8):1812-20. doi: 10.1002/cncr.23377. Cancer. 2008. PMID: 18318432 Free article. Clinical Trial.

4

First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.

Maza S, Kiewe P, Munz DL, Korfel A, Hamm B, Jahnke K, Thiel E. Maza S, et al. Among authors: kiewe p. Neuro Oncol. 2009 Aug;11(4):423-9. doi: 10.1215/15228517-2008-108. Epub 2008 Dec 5. Neuro Oncol. 2009. PMID: 19060176 Free PMC article. Clinical Trial.

5

Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort.

Kiewe P, Fischer L, Martus P, Thiel E, Korfel A. Kiewe P, et al. Neuro Oncol. 2010 Apr;12(4):409-17. doi: 10.1093/neuonc/nop053. Epub 2010 Jan 25. Neuro Oncol. 2010. PMID: 20308318 Free PMC article. Clinical Trial.

6

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma.

Korfel A, Schlegel U, Herrlinger U, Dreyling M, Schmidt C, von Baumgarten L, Pezzutto A, Grobosch T, Kebir S, Thiel E, Martus P, Kiewe P. Korfel A, et al. Among authors: kiewe p. J Clin Oncol. 2016 May 20;34(15):1757-63. doi: 10.1200/JCO.2015.64.9897. Epub 2016 Mar 14. J Clin Oncol. 2016. PMID: 26976424 Clinical Trial.

7

Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma.

Fischer L, Korfel A, Kiewe P, Neumann M, Jahnke K, Thiel E. Fischer L, et al. Among authors: kiewe p. Ann Hematol. 2009 Feb;88(2):133-9. doi: 10.1007/s00277-008-0575-8. Epub 2008 Aug 5. Ann Hematol. 2009. PMID: 18679681

8

Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors.

Kiewe P, Thiel E, Reinwald M, Korfel A. Kiewe P, et al. J Neurooncol. 2011 Jul;103(3):629-34. doi: 10.1007/s11060-010-0434-z. Epub 2010 Oct 13. J Neurooncol. 2011. PMID: 20941526

9

CXCL13 and CXCL12 in central nervous system lymphoma patients.

Fischer L, Korfel A, Pfeiffer S, Kiewe P, Volk HD, Cakiroglu H, Widmann T, Thiel E. Fischer L, et al. Among authors: kiewe p. Clin Cancer Res. 2009 Oct 1;15(19):5968-73. doi: 10.1158/1078-0432.CCR-09-0108. Epub 2009 Sep 22. Clin Cancer Res. 2009. PMID: 19773382

10

Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.

Jahnke K, Hummel M, Korfel A, Burmeister T, Kiewe P, Klasen HA, Müller HH, Stein H, Thiel E. Jahnke K, et al. Among authors: kiewe p. J Clin Oncol. 2006 Oct 10;24(29):4754-7. doi: 10.1200/JCO.2006.06.7165. Epub 2006 Sep 11. J Clin Oncol. 2006. PMID: 16966685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page